24.3 Percent of U.S. Adults Had Chronic Pain in Past Three Months in 2023
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 21, 2024 -- In 2023, 24.3 percent of U.S. adults had chronic pain in the previous three months, according to a November data brief published by the National Center for Health Statistics.
Jacqueline W. Lucas, M.P.H., and Inderbir Sohi, M.S.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, used data from the 2023 National Health Interview Survey to provide updated percentages of adults who experienced chronic pain and high-impact chronic pain in the previous three months.
The researchers found that 24.3 percent of adults had chronic pain and 8.5 percent of adults had chronic pain that frequently limited life or work activities (high-impact chronic pain) in the previous three months in 2023. With age, both chronic pain and high-impact chronic pain increased. The likelihood of having chronic pain was significantly higher for American Indian and Alaska Native non-Hispanic adults versus Asian non-Hispanic and Hispanic adults (30.7 percent versus 11.8 and 17.1 percent, respectively). With decreasing urbanization level, there was an increase seen in the percentage of adults with chronic pain and high-impact chronic pain.
"Women were more likely than men to experience chronic pain," the authors write. "Chronic pain was also generally higher in American Indian and Alaska Native adults and those age 65 and older. Similarly, high-impact chronic pain was higher in women, American Indian and Alaska Native adults, and those age 65 and older."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-22 12:00
Read more
- Discontinuing Cholinesterase When Starting Memantine Not Tied to Institutionalization Care
- What's the Link Between Memory Problems and Sexism?
- Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer
- Most U.S. Adults Want to Be Asked About Mental Health at Primary Care Visits
- Almost a Third of U.S. Retail Pharmacies Have Closed Since 2010
- FDA Approves Alhemo (concizumab-mtci) to Prevent or Reduce Bleeding Episodes in People with Hemophilia A or B with Inhibitors
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions